ISRCTN36731786已完成不适用
Dose finding for a safe and efficacious combination of chloroquine (CQ) and methylene blue in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso
DSM Fine Chemicals (Austria)0 个研究点目标入组 576 人开始时间: 2005年10月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 576
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Children (6-59 months), with uncomplicated falciparum malaria, =2000 Plasmodium falciparum, Burkinabe nationality
排除标准
- •1. Complicated or severe malaria
- •2. Hospitalised before for the same trial
- •3. Any apparent significant disease other than malaria
- •4. Hyperparasitaemia (>100,000/µl)
- •5. Patient is included in another trial
研究者
相似试验
尚未招募
不适用
Identifying the minimal dose and optimal combination of high-intensity aerobic interval training (HIIT) and strength training to improve physical fitness and cardiometabolic risk markers in sedentary adults – a randomized-controlled pilot and feasibility studyPrevention: physical fitness and cardiometabolic risk in sedentary adultsDRKS00012688niversitätsklinikum Mannheim40
招募中
2 期
Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE)2024-518138-10-00Association Gercor93
已完成
不适用
ReoGlio: REOLYSIN® plus GM-CSF in combination with standard of care chemotherapy and radiotherapy for patients with glioblastoma multiforme (GBM)Specialty: Cancer, Primary sub-specialty: Brain CancerUKCRC code/ Disease: Cancer/ Malignant neoplasms of eye, brain and other parts of central nervous systemCancerGlioblastoma multiformeISRCTN70044565niversity of Leeds24
进行中（未招募）
1 期
Efficacy and Safety of Fixed-Dose Combinationatorvastatin / amlodipine / perindopril versus Fixed-Dose Combination of atorvastatin / amlodipine in Patients with Hypertension and Dyslipidemia.Hypertension and dyslipidemiaMedDRA version: 20.0Level: HLTClassification code 10020774Term: Vascular hypertensive disorders NECSystem Organ Class: 100000004866MedDRA version: 21.0Level: LLTClassification code 10058110Term: DyslipidemiaSystem Organ Class: 100000004861EUCTR2014-005378-12-ITINSTITUT DE RECHERCHES INTERNATIONALES SERVIER854
已完成
1 期
A Single Oral Dose Study of DUR-928 in Nonalcoholic Steatohepatitis (NASH) Patients and Healthy Volunteersonalcoholic Steatohepatitis (NASH)Nonalcoholic Steatohepatitis (NASH)Metabolic and Endocrine - Other metabolic disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12615001355561INC Research32